Germany flexes its muscles on foreign investment

Germany flexes its muscles on foreign investment

June 25, 2020, Financial Times

Horst Henschen is quoted in the Financial Times regarding Germany’s investment into CureVac, a biopharmaceutical company attempting to find a COVID-19 vaccine. Mr. Henschen says, “Kuka was the trigger, but it’s a general policy shift. Ten years ago, Germany, an export country, was very much for globalization and no one thought of introducing hurdles. The shift is serious, and COVID-19 accelerated it.”